Kymera Therapeutics

Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer

Key Appointment to Advance Pipeline of Targeted Protein Degradation Therapeutics into the Clinic Cambridge, Mass. (September 20, 2018) – Kymera Therapeutics LLC, a biotechnology company pioneering targeted protein degradation as a transformative new approach to creating breakthrough medicines for